Table 2 Clinical outcomes of the LHOTD tertile groups with agonist and antagonist regimens
Variables | Agonist regimen | Antagonist regimen | ||||||
|---|---|---|---|---|---|---|---|---|
T1 (< 0.56) N = 2113 | T2 (0.56–0.84) N = 2159 | T3 (> 0.84) N = 2186 | P-value | T1 (< 1.98) N = 956 | T2 (1.98–3.61) N = 959 | T3 (> 3.61) N = 961 | P-value | |
Number of oocytes retrieved | 11.04 ± 4.45 a | 10.88 ± 4.34 a | 10.57 ± 4.34 b | 0.001 | 9.00 ± 4.74 a | 8.22 ± 4.51 b | 7.23 ± 4.35 c |  < 0.001 |
2PN rate | 57.1 (41.2–71.4) | 55.6 (40–71.4) | 57.1 (40–71.4) | 0.396 | 52.9 (38.5–70.0) | 55.6 (40.0–75.0) | 55.6 (38.5–75.0) | 0.062 |
Number of embryos transferred, n (% of total) | ||||||||
 1 | 258 (12.2) | 255 (11.8) | 276 (12.6) | 0.714 | 175 (18.3) a | 186 (19.4) a | 235 (24.5) b | 0.002 |
 2 | 1855 (87.8) | 1904 (88.2) | 1910 (87.4) | 781 (81.7) a | 773 (80.6) a | 726 (75.5) b | ||
Clinical pregnancy, n (% of ET cycles) | 875 (41.4) | 985 (45.6) | 1083 (49.5) |  < 0.001 | 344 (36.0) | 370 (38.6) | 369 (38.4) | 0.424 |
 Ectopic pregnancy, n (% of clinical pregnancy) | 38 (4.3) | 43 (4.4) | 28 (2.6) | 0.050 | 21 (6.1) | 17 (4.6) | 21 (5.7) | 0.653 |
 Early pregnancy loss, n (% of clinical pregnancy) | 112 (12.8) | 115 (11.7) | 109 (10.1) | 0.159 | 45 (13.1) | 48 (13.0) | 53 (14.4) | 0.829 |
 Ongoing pregnancy, n (% of clinical pregnancy) | 730 (83.4) | 831 (84.4) | 953 (88) | 0.009 | 279 (81.1) | 307 (83.0) | 297 (80.5) | 0.664 |
Live births, n (% of ET cycles) | 697 (33.0) | 783 (36.3) | 913 (41.8) |  < 0.001 | 265 (27.7) | 286 (29.8) | 281 (29.2) | 0.578 |